Cargando…
Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood
Asthma with bronchial hypersecretion is a type of asthma that is poorly studied. Its pathogenesis is not well understood, but is probably related to innate impaired immunity, particularly with toll-like receptors (TLRs) and secretory mucins (MUC). OBJECTIVES: 1) Define the clinical and inflammatory...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644553/ https://www.ncbi.nlm.nih.gov/pubmed/29066918 http://dx.doi.org/10.2147/JAA.S142200 |
_version_ | 1783271746404614144 |
---|---|
author | Crespo-Lessmann, Astrid Mateus, Eder Torrejón, Montserrat Belda, Alicia Giner, Jordi Vidal, Silvia Sibila, Oriol Plaza, Vicente |
author_facet | Crespo-Lessmann, Astrid Mateus, Eder Torrejón, Montserrat Belda, Alicia Giner, Jordi Vidal, Silvia Sibila, Oriol Plaza, Vicente |
author_sort | Crespo-Lessmann, Astrid |
collection | PubMed |
description | Asthma with bronchial hypersecretion is a type of asthma that is poorly studied. Its pathogenesis is not well understood, but is probably related to innate impaired immunity, particularly with toll-like receptors (TLRs) and secretory mucins (MUC). OBJECTIVES: 1) Define the clinical and inflammatory phenotype of asthma with bronchial hypersecretion of mucus. 2) Compare the type of mucin present in induced sputum (IS) of patients with and without bronchial hypersecretion. 3) Determine the expression of TLRs in IS and blood of asthmatics with and without bronchial hypersecretion. MATERIALS AND METHODS: Cross-sectional study which included 43 non-smoking asthmatic patients without bronchiectasis, 19 with bronchiectasis, and 24 without bronchial hypersecretion. All patients underwent the following: IS, spirometry, fractional exhaled nitric oxide, prick test, total immunoglobulin E (IgE), and blood albumin. Analysis of mucins was determined by ELISA and expression of TLR2 and TLR4 by flow cytometry. The level of asthma control was determined by the Asthma Control Test (ACT) questionnaire and quality of life was assessed by the reduced version of the Asthma Quality of Life Questionnaire (mini-AQLQ). RESULTS: Asthmatics with bronchial hypersecretion were significantly older (62.6 years vs 48.5 years; p=0.02); had greater severity (persistent severe asthma 94.7% vs 29.2%; p=0.000); a higher proportion of nasal polyposis (36.8% vs 8.3%; p=0.022); less control of asthma (73.7% vs 8.3%; p=0,000); a higher proportion of asthma with negative prick test (68.4% vs 16.6%; p=0.001), and lower levels of IgE (113.4 IU/mL vs 448 IU/mL; p=0.007), compared with asthmatics without bronchial hypersecretion. Significant differences were observed neither in the expression of TLRs 2 and 4 in inflammatory cells of IS or peripheral blood, nor in the expression of mucins between both groups. CONCLUSION: Asthma patients with bronchial hypersecretion have more severe and uncontrolled disease, with poor quality of life as well as a non-allergic inflammatory phenotype. Within the mechanisms involving these differences, it does not appear that mucins and TLRs play an important role. |
format | Online Article Text |
id | pubmed-5644553 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-56445532017-10-24 Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood Crespo-Lessmann, Astrid Mateus, Eder Torrejón, Montserrat Belda, Alicia Giner, Jordi Vidal, Silvia Sibila, Oriol Plaza, Vicente J Asthma Allergy Original Research Asthma with bronchial hypersecretion is a type of asthma that is poorly studied. Its pathogenesis is not well understood, but is probably related to innate impaired immunity, particularly with toll-like receptors (TLRs) and secretory mucins (MUC). OBJECTIVES: 1) Define the clinical and inflammatory phenotype of asthma with bronchial hypersecretion of mucus. 2) Compare the type of mucin present in induced sputum (IS) of patients with and without bronchial hypersecretion. 3) Determine the expression of TLRs in IS and blood of asthmatics with and without bronchial hypersecretion. MATERIALS AND METHODS: Cross-sectional study which included 43 non-smoking asthmatic patients without bronchiectasis, 19 with bronchiectasis, and 24 without bronchial hypersecretion. All patients underwent the following: IS, spirometry, fractional exhaled nitric oxide, prick test, total immunoglobulin E (IgE), and blood albumin. Analysis of mucins was determined by ELISA and expression of TLR2 and TLR4 by flow cytometry. The level of asthma control was determined by the Asthma Control Test (ACT) questionnaire and quality of life was assessed by the reduced version of the Asthma Quality of Life Questionnaire (mini-AQLQ). RESULTS: Asthmatics with bronchial hypersecretion were significantly older (62.6 years vs 48.5 years; p=0.02); had greater severity (persistent severe asthma 94.7% vs 29.2%; p=0.000); a higher proportion of nasal polyposis (36.8% vs 8.3%; p=0.022); less control of asthma (73.7% vs 8.3%; p=0,000); a higher proportion of asthma with negative prick test (68.4% vs 16.6%; p=0.001), and lower levels of IgE (113.4 IU/mL vs 448 IU/mL; p=0.007), compared with asthmatics without bronchial hypersecretion. Significant differences were observed neither in the expression of TLRs 2 and 4 in inflammatory cells of IS or peripheral blood, nor in the expression of mucins between both groups. CONCLUSION: Asthma patients with bronchial hypersecretion have more severe and uncontrolled disease, with poor quality of life as well as a non-allergic inflammatory phenotype. Within the mechanisms involving these differences, it does not appear that mucins and TLRs play an important role. Dove Medical Press 2017-10-12 /pmc/articles/PMC5644553/ /pubmed/29066918 http://dx.doi.org/10.2147/JAA.S142200 Text en © 2017 Crespo-Lessmann et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Crespo-Lessmann, Astrid Mateus, Eder Torrejón, Montserrat Belda, Alicia Giner, Jordi Vidal, Silvia Sibila, Oriol Plaza, Vicente Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood |
title | Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood |
title_full | Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood |
title_fullStr | Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood |
title_full_unstemmed | Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood |
title_short | Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood |
title_sort | asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644553/ https://www.ncbi.nlm.nih.gov/pubmed/29066918 http://dx.doi.org/10.2147/JAA.S142200 |
work_keys_str_mv | AT crespolessmannastrid asthmawithbronchialhypersecretionexpressionofmucinsandtolllikereceptorsinsputumandblood AT mateuseder asthmawithbronchialhypersecretionexpressionofmucinsandtolllikereceptorsinsputumandblood AT torrejonmontserrat asthmawithbronchialhypersecretionexpressionofmucinsandtolllikereceptorsinsputumandblood AT beldaalicia asthmawithbronchialhypersecretionexpressionofmucinsandtolllikereceptorsinsputumandblood AT ginerjordi asthmawithbronchialhypersecretionexpressionofmucinsandtolllikereceptorsinsputumandblood AT vidalsilvia asthmawithbronchialhypersecretionexpressionofmucinsandtolllikereceptorsinsputumandblood AT sibilaoriol asthmawithbronchialhypersecretionexpressionofmucinsandtolllikereceptorsinsputumandblood AT plazavicente asthmawithbronchialhypersecretionexpressionofmucinsandtolllikereceptorsinsputumandblood |